| 氟氧头孢对呼吸道感染疗效的临床观察 |
| 点此下载全文 |
| 引用本文：刘又宁,余秉翔,方向群,王睿.氟氧头孢对呼吸道感染疗效的临床观察[J].药学实践杂志,1995,(2):76~80 |
| 摘要点击次数: 1271 |
| 全文下载次数: 876 |
|
|
| 中文摘要:本文对比了氟氧头孢(flomoxef,FMX)与对照药头孢美唑(cefmetazone,CMZ)对呼吸道感染患者的临床疗效和不良反应,尽管随机分组中FMX组患者年龄偏大,基础疾病相对较多,但FMX组痊愈率为63.6%,有效率为90.9%,与CMZ组无显着差异;尤其FMX对金黄色葡萄球菌感染最有效(100%痊愈),细菌清除率(100%)亦比CMZ组(88.9%)高,未见任何不良反应,从而提示FMX为一安全有效的新抗生素。 |
| 中文关键词:氟氧头孢(flomoxef) 临床疗效 不良反应 |
| |
| Observation on clinical effects of flomoxef in treatment of infections of respiratory tract |
|
|
| Abstract:The clinical response and adverse reaction of flomoxef (FMX) in treatment of the patients with respiratory infections were compared with controlled drug-cefmetazone(CMZ) in the study. The results showed that although the age of the patients in group FMZ was older and the serious underground diseases were more than group CMX, but in group FMX, the cured rate was 63.6%, the effective rate was 90.9%, there was no significant difference between the two groups. Especially FMX was the best drug to treat the infections caused by S. aureus(cured rate was 100%). The rate of bacteria clearance of FMX was higher(100%) than CMZ(88.9%), there was no adverse reaction in the group.It is suggested that FMX was a safe and effective antibiotic. |
| keywords:flomoxef clinical respone adverse reaction |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
|
|
|
